SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-049936
Filing Date
2020-09-10
Accepted
2020-09-10 12:13:08
Documents
2
Period of Report
2020-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1548
2 POA DOCUMENT poa.txt EX-24.3_936599 3421
  Complete submission text file 0001209191-20-049936.txt   6308
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UROGEN PHARMA LTD. 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540
Business Address
Smith Jason Drew (Reporting) CIK: 0001821479 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38079 | Film No.: 201168174